Artesunate ameliorates DSS-induced ulcerative colitis by protecting intestinal barrier and inhibiting inflammatory response
- 2 January 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Inflammation
- Vol. 43 (2), 765-776
- https://doi.org/10.1007/s10753-019-01164-1
Abstract
There are very few reports on the protective effect of artesunate (ARS) in ulcerative colitis (UC). This study focused on the efficacy of ARS on intestinal barrier, inflammatory response, and potential mechanism in dextran sulfate sodium (DSS)-induced ulcerative colitis in mice. The results suggested that ARS treatment markedly alleviated DSS-induced clinical symptoms by relieving body weight loss, the disease activity index (DAI) score, and preventing colonic shortening. HE staining and scanning electron microscope analysis revealed that ARS treatment significantly protected the integrity of intestinal barrier through alleviating DSS-induced erosion of surface epithelial cells, reduction of goblet cells, and destruction of the crypt accompanied with inflammatory cells infiltration. Immunofluorescence histochemical staining and western blot assay confirmed that ARS notably inhibited the loss of Muc2 and claudin-1 in mucosal layer with a relative higher level of Bcl-2/Bax ratio and, moreover, inhibited cleaved-caspase-3 expression in colon tissue. In addition, this study reconfirmed the anti-inflammatory function of ARS evidenced by remarkably suppressing the phosphorylation of nuclear factor-κBα (IκBα) and NF-κB p65 and the expression of IL-1β, IL-6, and TNF-α while enhancing IL-10 expression. Taken together, these data highlight that ARS has the protective effect on UC through maintaining the expression of intestinal mucosal barrier-related proteins, suppressing the apoptosis and inflammatory response. This study may facilitate to understand the action mechanism of ARS against UC.Keywords
Funding Information
- National Natural Science Foundation of China (31672595)
- Priority Academic Program Development of Jiangsu Higher Education Institutions
This publication has 39 references indexed in Scilit:
- Methods of Inducing Inflammatory Bowel Disease in MiceCurrent Protocols in Pharmacology, 2009
- Intestinal mucosal barrier function in health and diseaseNature Reviews Immunology, 2009
- Mechanism of cytokine modulation of epithelial tight junction barrierFrontiers in Bioscience-Landmark, 2009
- Mouse models of inflammatory bowel diseaseAdvanced Drug Delivery Reviews, 2007
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- Muc2-Deficient Mice Spontaneously Develop Colitis, Indicating That MUC2 Is Critical for Colonic ProtectionGastroenterology, 2006
- Interleukin-13 Is the Key Effector Th2 Cytokine in Ulcerative Colitis That Affects Epithelial Tight Junctions, Apoptosis, and Cell RestitutionGastroenterology, 2005
- Interleukin-13 Is the Key Effector Th2 Cytokine in Ulcerative Colitis That Affects Epithelial Tight Junctions, Apoptosis, and Cell RestitutionGastroenterology, 2005
- Leaks in the epithelial barrier caused by spontaneous and TNF‐α‐induced single‐cell apoptosisThe FASEB Journal, 2000
- Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitisGut, 1999